Samarendra Kumar Ray - Publications

Affiliations: 
1985 University of Calcutta, Kolkata, West Bengal, India 

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Mohan N, Chakrabarti M, Banik NL, Ray SK. Combination of LC3 shRNA plasmid transfection and genistein treatment inhibited autophagy and increased apoptosis in malignant neuroblastoma in cell culture and animal models. Plos One. 8: e78958. PMID 24205354 DOI: 10.1371/Journal.Pone.0078958  0.365
2013 Mohan N, Ai W, Chakrabarti M, Banik NL, Ray SK. KLF4 overexpression and apigenin treatment down regulated anti-apoptotic Bcl-2 proteins and matrix metalloproteinases to control growth of human malignant neuroblastoma SK-N-DZ and IMR-32 cells. Molecular Oncology. 7: 464-74. PMID 23317647 DOI: 10.1016/J.Molonc.2012.12.002  0.324
2012 Hossain MM, Banik NL, Ray SK. Survivin knockdown increased anti-cancer effects of (-)-epigallocatechin-3-gallate in human malignant neuroblastoma SK-N-BE2 and SH-SY5Y cells. Experimental Cell Research. 318: 1597-610. PMID 22507272 DOI: 10.1016/J.Yexcr.2012.03.033  0.328
2011 Karmakar S, Choudhury SR, Banik NL, Ray SK. Induction of Mitochondrial Pathways and Endoplasmic Reticulum Stress for Increasing Apoptosis in Ectopic and Orthotopic Neuroblastoma Xenografts. Journal of Cancer Therapy. 2: 77-90. PMID 22468231 DOI: 10.4236/Jct.2011.22009  0.353
2011 Mohan N, Banik NL, Ray SK. Synergistic efficacy of a novel combination therapy controls growth of Bcl-x(L) bountiful neuroblastoma cells by increasing differentiation and apoptosis. Cancer Biology & Therapy. 12: 846-54. PMID 21878749 DOI: 10.4161/Cbt.12.9.17715  0.31
2011 Karmakar S, Choudhury SR, Banik NL, Ray SK. N-(4-Hydroxyphenyl) Retinamide Potentiated Anti-tumor Efficacy of Genistein in Human Ewing's Sarcoma Xenografts. World Journal of Oncology. 2: 53-63. PMID 21822457 DOI: 10.4021/Wjon301W  0.31
2011 Mohan N, Banik NL, Ray SK. Combination of N-(4-hydroxyphenyl) retinamide and apigenin suppressed starvation-induced autophagy and promoted apoptosis in malignant neuroblastoma cells. Neuroscience Letters. 502: 24-9. PMID 21801811 DOI: 10.1016/J.Neulet.2011.07.016  0.4
2010 George J, Banik NL, Ray SK. Genistein induces receptor and mitochondrial pathways and increases apoptosis during BCL-2 knockdown in human malignant neuroblastoma SK-N-DZ cells. Journal of Neuroscience Research. 88: 877-86. PMID 19813266 DOI: 10.1002/Jnr.22244  0.345
2010 Roy Choudhury S, Karmakar S, Banik NL, Ray SK. Synergistic efficacy of sorafenib and genistein in growth inhibition by down regulating angiogenic and survival factors and increasing apoptosis through upregulation of p53 and p21 in malignant neuroblastoma cells having N-Myc amplification or non-amplification. Investigational New Drugs. 28: 812-24. PMID 19777160 DOI: 10.1007/S10637-009-9324-7  0.339
2009 Karmakar S, Davis KA, Choudhury SR, Deeconda A, Banik NL, Ray SK. Bcl-2 inhibitor and apigenin worked synergistically in human malignant neuroblastoma cell lines and increased apoptosis with activation of extrinsic and intrinsic pathways. Biochemical and Biophysical Research Communications. 388: 705-10. PMID 19695221 DOI: 10.1016/J.Bbrc.2009.08.071  0.343
2009 Karmakar S, Choudhury SR, Banik NL, Ray SK. Combination of N-(4-hydroxyphenyl) retinamide and genistein increased apoptosis in neuroblastoma SK-N-BE2 and SH-SY5Y xenografts. Neuroscience. 163: 286-95. PMID 19540315 DOI: 10.1016/J.Neuroscience.2009.06.037  0.313
2009 Mohan N, Karmakar S, Choudhury SR, Banik NL, Ray SK. Bcl-2 inhibitor HA14-1 and genistein together adeptly down regulated survival factors and activated cysteine proteases for apoptosis in human malignant neuroblastoma SK-N-BE2 and SH-SY5Y cells. Brain Research. 1283: 155-66. PMID 19505441 DOI: 10.1016/J.Brainres.2009.05.097  0.329
Show low-probability matches.